National Cancer Center, Korea: Pancreatic Neoplasms trials
The registry lists 13 Pancreatic Neoplasms studies with National Cancer Center, Korea as lead sponsor. 3 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 5No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Development & Clinical Application of K-PaC Registry Version 2.0Enrolling by invitationNCT07171515
- Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary CancersRecruitingNCT06135896Phase 2
- Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam TherapyEnrolling by invitationNCT04466189
- Survival Rate and Treatment Cost in Patients With Pancreatic Cancer: An Analysis Using NHIS Database and K-PaC Registry Focusing on Liposomal IrinotecanCompletedNCT04984174
- A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving ChemotherapyCompletedNCT04281511
- Preoperative Nutritional Support in Malnutritional Cancer PatientsCompletedNCT02626195Not applicable
- Diagnostic Laparoscopy in the Preoperative Staging of Pancreatobiliary CancerStatus unknownNCT02479984Not applicable
- Induction Chemotherapy With Gemcitabine and Cisplatin Followed by CCRT for Unresectable Pancreatic CarcinomaCompletedNCT01593475Phase 2
- Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PBCompletedNCT01589328Not applicable
- Pancreatic Enzyme Supplementation in Patients With Unresectable Pancreatic Cancer (PESUP)CompletedNCT01587534Phase 2
- Preoperative Chemoradiotherapy With Gemcitabine for Resectable Pancreatic CarcinomaTerminatedNCT01333124Phase 2
- Concurrent Chemo-radiotherapy With Capecitabine for Unresectable Locally Advanced Pancreatic CarcinomaStatus unknownNCT00658840Phase 2
- Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas CarcinomaTerminatedNCT00658801Phase 1